Ignite Creation Date:
2025-12-24 @ 3:36 PM
Ignite Modification Date:
2026-06-14 @ 9:41 AM
Study NCT ID:
NCT05263492
Status:
TERMINATED
Last Update Posted:
2025-10-02
First Post:
2022-02-21
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study of Lenvatinib w/ Pembro in Black Participants w/Mismatch Repair-Prof Recurrent Endometrial Cancer
Sponsor:
Virginia Commonwealth University
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
MCC-21-18659
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None